TABLE 4.
Patient demographic characteristics for 38,835 MDR E. coli urinary tract isolates as reported to TSN 1 January to 30 September 2000
| Patient category | Total no. of isolates | % Isolates resistant to:
|
% MDR isolates (no.) | ||||
|---|---|---|---|---|---|---|---|
| Ampicillin | Cephalothin | Nitrofurantoin | SXT | Ciprofloxacin | |||
| Gender | |||||||
| Female | 32,999 | 38.6 | 14.3 | 0.8 | 18.7 | 3.2 | 6.6 (2,189) |
| Male | 4,642 | 39.3 | 18.5 | 1.4 | 20.1 | 7.6 | 10.4 (485) |
| Age | |||||||
| ≤17 yr | 5,144 | 46.5 | 14.3 | 0.8 | 22.7 | 0.6 | 6.8 (350) |
| 18–65 yr | 19,468 | 39.0 | 13.7 | 0.5 | 18.3 | 2.7 | 6.1 (1,193) |
| >65 yr | 12,029 | 33.2 | 15.8 | 1.5 | 17.3 | 7.1 | 8.7 (1,047) |
| Location | |||||||
| Inpatient | 7,936 | 40.2 | 17.5 | 1.0 | 17.5 | 5.0 | 7.6 (605) |
| Outpatient | 30,522 | 38.4 | 14.0 | 0.7 | 19.2 | 3.2 | 6.9 (2,105) |
a
Of the 38,835 isolates tested against all five antimicrobials, demographic data was not available for all isolates: gender was not reported for 1,194 isolates, age was not reported for 2,194 isolates, and patient location was not reported for 377 isolates.